Inflammatory Bowel Disease Market to Register Incremental Growth During the Forecast ...

Summary

The article provides a comprehensive overview of the Inflammatory Bowel Disease (IBD) market, covering its epidemiology, drug uptake, and therapeutic advances—including treatment with Infliximab—highlighting key players and future trends in autoimmune and gastrointestinal disorders associated with abdominal pain.